Search
for
Sort by
Research 61–90 of 1000+
- Nonclassic Congenital Adrenal Hyperplasia
- Progenitor Cell Dysfunctions Underlie Some Diabetic Complications
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- The Medical and Psychosocial Associations of Alopecia: Recognizing Hair Loss as More Than a Cosmetic Concern
- Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
- Recommendations of endocrine treatment for patients with gender dysphoria
- The genetic link between thyroid dysfunction and alopecia areata: a bidirectional two-sample Mendelian randomization study
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Dysfunction of keratinocyte adhesion
- Exploring phytoandrogens: A review of their potential in health and medicine
- Influence of The Anabolic Steroid Usage on The Physical Health: A Review
- STEROID HORMONES IN GERIATRICS
- MitoQ upregulates CYP19A1 to protect dermal papilla cells from DHT-induced mitochondrial dysfunction and apoptosis in androgenetic alopecia
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Review Article: Practical Aspects of Testosterone Deficiency Syndrome in Clinical Urology
- PATHOGENETIC FEATURES OF THE INFLUENCE OF A PAST CORONAVIRUS INFECTION IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- Endocrinologia e Medicina Estética Ed. X
- Cutaneous Manifestations of Chronic Kidney Disease: A Narrative Review
- Absence of Heart Failure in Severe Cardiac and Autonomic Amyloidosis: The Essential Role of Sympathetic Activation and Venous Tone in the Development of the Congestive Heart Failure Syndrome